Results 191 to 200 of about 1,647,355 (316)
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht +3 more
wiley +1 more source
Microbial cell-free DNA for rapid pathogen identification in clinical diagnostics: a proof of concept study. [PDF]
Banz M +12 more
europepmc +1 more source
Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review
Simon Knight +2 more
openalex +2 more sources
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski +12 more
wiley +1 more source
Diagnostic performance of donor-derived cell-free DNA for acute rejection in kidney allograft biopsies. [PDF]
Nakamura MR +6 more
europepmc +1 more source
Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung
Moupali Ghosh +4 more
openalex +1 more source
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source
Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer. [PDF]
Li JJN +10 more
europepmc +1 more source

